Study Efficacy and Safety of INC280 in Patients With Advanced Hepatocellular Carcinoma.
Clinical trial NCT01737827 · TERMINATED
Trial details
- NCT number
- NCT01737827
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-25
- Primary completion
- 2023-04-24
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.